• Users Online: 243
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Evolving role of immunotherapy in head-and-neck cancers: A systemic review

Chanana Raajit, Noronha Vanita, Joshi Amit, Patil Vijay, Prabhash Kumar

Year : 2018| Volume: 6| Issue : 1 | Page no: 2-11

   This article has been cited by
 
1 First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
Antoine Italiano,Philippe A. Cassier,Chia-Chi Lin,Tuomo Alanko,Katriina J. Peltola,Anas Gazzah,Her-Shyong Shiah,Emiliano Calvo,Andrés Cervantes,Desamparados Roda,Diego Tosi,Bo Gao,Michael Millward,Lydia Warburton,Minna Tanner,Stefan Englert,Stacie Lambert,Apurvasena Parikh,Daniel E. Afar,Gregory Vosganian,Victor Moreno
Cancer Immunology, Immunotherapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Immunoregulatory Potential of Exosomes Derived from Cancer Stem Cells
Shannon M Clayton,Joehleen Archard,Joseph Wagner,D Gregory Farwell,Arnaud F Bewley,Angela Beliveau,Andrew C Birkeland,Shyam Rao,Marianne Abouyared,Peter Belafsky,Johnathon D Anderson
Stem Cells and Development. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 Immunotherapy and its advances in the management of head-and-neck cancer
SajadAhmad Buch,Laxmikanth Chatra
CHRISMED Journal of Health and Research. 2019; 6(4): 199
[Pubmed]  [Google Scholar] [DOI]

 

Read this article